… a Big Pharma villian. Yesterday, the Danish pharma made an … quickly, the tide turned. Revenue from the semaglutide franchise began … rival medicines jumped. Compounding pharmacies zeroed in on the drug … he said on Novo’s second-quarter earnings call, where he …

… in Big Pharma’s recent … Q2 were cash-pay, bypassing traditional PBM gatekeeping entirely. Behind the revenue … supercomputer in pharma, intended to … obesity drugs, pharma rankings, pharma revenue, pharmaceutical industry, pharmaceutical valuation, Tirzepatide, …

… record of building successful profitable pharmaceutical businesses of significant scale. … paused at the end of second quarter, but we’ll continue … saw in Q2 we had a 39% revenue growth with … to be operating profit — in operating profit position next year. …

… profit at Rs 1,353.37 crore for the second quarter … Consolidated total revenue from operations in the second quarter stood at … said. In the second quarter, the pharmaceuticals segment clocked revenue of Rs 7 … ago.New ventures registered revenue of Rs 350.68 …

… Transcript October 29, 2025 Vanda Pharmaceuticals Inc. misses on earnings … to the second quarter of 2025. The increase in Fanapt revenue between … to the second quarter and then again from the second quarter to the … growth Q1 to Q2 and 11% growth Q2 to Q3 from …

… net profit at ₹131.52 crore in the second quarter ended … filing. Consolidated revenue from operations in the second quarter stood at … Commenting on the performance, Strides Pharma Science MD & … in Q2 FY26 'other regulated markets' revenue was …

… June 30, 2025. Financial Results (Q2 FY2026) - YoY Comparison The … . The company has posted net profit /; (loss) of Rs.227. … 30, 2025 as against net profit /; (loss) of Rs.3423. … 30, 2024. Shares of Strides Pharma Science Limited was last trading …

… 2026. Second Quarter Fiscal Year 2026 Highlights: Record second quarter results for revenue, gross profit, operating … , Food, Agriculture, and Pharmaceutical businesses. Food, Agriculture, and Pharmaceutical had previously been …

Onconic Therapeutics, a Jeil Pharmaceutical subsidiary, posted its … billion won in milestone revenue from its Chinese partner, … second quarter, when revenue was 9.4 billion won and operating profit … Onconic raised its 2025 revenue guidance in April from …

… companies that will announce their second-quarter earnings today. It has … double-digit rise in Q2 profit, while revenue could see a growth … moderate sequentially. KIE pegs Q2 profit for BPCL at ₹2397 … Finance Ltd., Tatva Chintan Pharma Chem Ltd., Teesta Agro …